Genome Biology (Jul 2019)

Cell type-specific epigenetic links to schizophrenia risk in the brain

  • Isabel Mendizabal,
  • Stefano Berto,
  • Noriyoshi Usui,
  • Kazuya Toriumi,
  • Paramita Chatterjee,
  • Connor Douglas,
  • Iksoo Huh,
  • Hyeonsoo Jeong,
  • Thomas Layman,
  • Carol A. Tamminga,
  • Todd M. Preuss,
  • Genevieve Konopka,
  • Soojin V. Yi

DOI
https://doi.org/10.1186/s13059-019-1747-7
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Background The importance of cell type-specific epigenetic variation of non-coding regions in neuropsychiatric disorders is increasingly appreciated, yet data from disease brains are conspicuously lacking. We generate cell type-specific whole-genome methylomes (N = 95) and transcriptomes (N = 89) from neurons and oligodendrocytes obtained from brain tissue of patients with schizophrenia and matched controls. Results The methylomes of the two cell types are highly distinct, with the majority of differential DNA methylation occurring in non-coding regions. DNA methylation differences between cases and controls are subtle compared to cell type differences, yet robust against permuted data and validated in targeted deep-sequencing analyses. Differential DNA methylation between control and schizophrenia tends to occur in cell type differentially methylated sites, highlighting the significance of cell type-specific epigenetic dysregulation in a complex neuropsychiatric disorder. Conclusions Our results provide novel and comprehensive methylome and transcriptome data from distinct cell populations within patient-derived brain tissues. This data clearly demonstrate that cell type epigenetic-differentiated sites are preferentially targeted by disease-associated epigenetic dysregulation. We further show reduced cell type epigenetic distinction in schizophrenia.

Keywords